Summary of findings ‐ AZLI vs placebo
All‐cause mortality · adults and children with CF
Summary of findings ‐ AZLI showed no clear difference in mortality compared with placebo (moderate certainty).
1 finding from 1 review
- Antibiotic therapy for chronic infection with Burkholderia cepacia complex in people with cystic fibrosis 2021 · Cochrane Headline outcomes onlyRR 5.41 [0.27, 109.87]1 study · 100 participantsModerate